Cardiac Resynchronization. Individualized.

Myochron. Tailoring therapy to each and every CRT patient’s unique anatomy and physiology.

Learn More Today

Cardiac Resynchronization. Individualized.

Myochron. Tailoring therapy to each and every CRT patient’s unique anatomy and physiology.

Learn More Today

OVERVIEW

Mychron elevates heart failure therapy through precise and individualized optimization of cardiac resynchronization therapy (CRT).*

*The Myochron product is currently under development and has not been approved by regulatory authorities such as the FDA or other equivalent bodies outside the US. It is not available for sale, distribution, or commercial use at this time. The information provided on this website is for informational purposes only and should not be construed as medical advice, diagnosis, or treatment. Please consult with a qualified healthcare professional for any medical concerns or questions.

Mychron elevates heart failure therapy through precise and individualized optimization of cardiac resynchronization therapy (CRT).*

Ensuring each and every CRT patient realizes the full potential of therapy.

Many patients who receive CRT do not receive the full benefits of the therapy.¹

Over half of heart failure patients treated with CRT do not realize the full benefit of therapy, and many do not respond.

Myochron's aim is to turn non-responders into responders – improving heart function - a direct predictor of reduced hospitalization and mortality. Myochron's cloud-based platform helps all CRT patients live better lives by realizing the full benefit of therapy.

MYOCHRON CLOUD PLATFORM

Mapping the pathway to synchrony for the clinician - so that each and every CRT patient benefits.

The Myochron platform creates a map using it's unique cardiac synchronization index (CRI) - a measure of electrical dyssynchrony. This informs the clinician as to the optimal programming for each of their patients.

Individualized Electrical Dyssynchrony Maps

Maps that are unique to each patient provide recommendations for optimal programming. Unique considerations for each patient's clinical condition are accounted for and presented - thus ensuring each patient can achieve optimal synchrony and maximal response.

THE SOLUTION

More about Myochron's cloud platform

Learn More Today

Strong Clinical Data

Individualizing cardiac resynchronization to each patient's unique anatomy and electrophysiology optimizes CRT response.

Published Peer-Reviewed Research

Improved Ejection Fraction²

Reduced LV Size²

Cloud-Based Platform

Enjoy the benefits of our cloud-based platform, enabling collaboration, and seamless access to critical data from anywhere.

Flexibility

Scalability

Access Anywhere

Seamless Workflow Integration

CRT optimization fits seamlessly into existing clinical workflows and standard device check visits.

Less Than 1 Hour Visit

Easy Physician Sign-Off

Patient Leaves Optimized

BY THE NUMBERS

Myochron has robust clinical data supporting individualized CRT.

Woman in blue hat and sweater sitting on couch with laptop.

500+

Patients Treated

Patients with both new and existing devices can be individualized to the optimal settings in a single visit.

1.7M+

Patients with CRT

Millions of patients have existing CRT devices, and could benefit from individualized programming.

4.5%

Avg. Improvement in Ejection Fraction

Avg. Improvement in EF

A study in Heart Rhythm (2022) showed a 4.5% (absolute) improvement in Ejection Fraction compared to default CRT.²

$3-5K

Cost of Non-Response / Patient / Year

Cost of Non-Response

Non-responders have $3-5K per year in excess healthcare costs compared to responders.³

OUR WHY

“We implant a $30,000 device into sick patients with advanced heart failure and then throw our hands up in the air if they don’t improve as much as we expect. Over 50% of patients who are defined as non-responders do not undergo any change in their device settings, let alone a beneficial change. ”

Dr. Alan Bank

Chief Medical Officer & Co-Founder, Myochron

“We implant a $30,000 device into sick patients with advanced heart failure and then throw our hands up in the air if they don’t improve as much as we expect. Over 50% of patients who are defined as non-responders do not undergo any change in their device settings, let alone a beneficial change. ”

Dr. Alan Bank

Chief Medical Officer & Co-Founder, Myochron

“We implant a $30,000 device into sick patients with advanced heart failure and then throw our hands up in the air if they don’t improve as much as we expect. Over 50% of patients who are defined as non-responders do not undergo any change in their device settings, let alone a beneficial change. ”

Dr. Alan Bank

Chief Medical Officer & Co-Founder, Myochron

References

Daubert C, Behar N, et al. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. European Heart Journal. 2017 May 14;38(19):1463–1472

Brown CD, Burns KV, et. al, Bank AJ. CRT optimization in nonresponders using electrical dyssynchrony mapping. Heart Rhythm 2022;19:1965-73.

Varma N, Auricchio A, et al. The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy. Europace. 2021 Oct 9;23(10):1586-1595.

PUBLISHED RESEARCH

Discover our latest research

Research in peer-reviewed publications backs everything we do. Dive in to learn about the science backing our technology.

View All

Heart Rhythm 2022

Daubert C, Behar N, et al. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. European Heart Journal. 2017 May 14;38(19):1463–1472

Brown CD, Burns KV, et. al, Bank AJ. CRT optimization in nonresponders using electrical dyssynchrony mapping. Heart Rhythm 2022;19:1965-73.

Varma N, Auricchio A, et al. The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy. Europace. 2021 Oct 9;23(10):1586-1595.

MYOCHRON CLOUD PLATFORM

Cardiac Resynchronization. Individualized.

Cardiac Resynchronization. Individualized.

Mychron elevates heart failure therapy through precise and individualized optimization of cardiac resynchronization therapy (CRT).*

Mychron elevates heart failure therapy through precise and individualized optimization of cardiac resynchronization therapy (CRT).*

Over half of heart failure patients treated with CRT do not realize the full benefit of therapy, and many do not respond.

Mapping the pathway to synchrony for the clinician - so that each and every CRT patient benefits.

Individualized Electrical Dyssynchrony Maps

More about Myochron's cloud platform

More about Myochron's cloud platform

Individualizing cardiac resynchronization to each patient's unique anatomy and electrophysiology optimizes CRT response.

Enjoy the benefits of our cloud-based platform, enabling collaboration, and seamless access to critical data from anywhere.

CRT optimization fits seamlessly into existing clinical workflows and standard device check visits.

Myochron has robust clinical data supporting individualized CRT.

Patients Treated

Patients with CRT

Avg. Improvement in Ejection Fraction

Avg. Improvement in EF

Cost of Non-Response / Patient / Year

Cost of Non-Response

Dr. Alan Bank

Dr. Alan Bank

Dr. Alan Bank

Discover our latest research

CRT optimization in nonresponders and incomplete responders using electrical dyssynchrony mapping

Electrical dyssynchrony mapping and cardiac resynchronization therapy

Electrical wavefront fusion in heart failure patients with LBBB and CRT: implications for optimization.

Mapping the pathway to synchrony for the clinician - so that each and every CRT patient benefits.

Individualized Electrical Dyssynchrony Maps